Netherlands Compounding Pharmacies Market Size and Share Analysis - 2026 to 2033
Netherlands compounding pharmacies market is estimated to be valued at USD 484.70 Mn in 2026 and is expected to reach USD 798.7 Mn in 2033, exhibiting a compound annual growth rate (CAGR) of 7.4% from 2026 to 2033.
Key Takeaways
- Based on Product Type, the Oral Medications segment is expected to lead the market with 43.7% share in 2026.
- Based on Application, the Adult segment is expected to hold 51.3% share of the market in 2026.
- Based on Therapeutic Areas, the Hormone Replacement Therapy segment is projected to account for 56.2% share of the market in 2026.
- Based on Facility, the Community Pharmacies segment is projected to capture 60% of the market in 2026.
Market Overview
The market for compounding pharmacies in the Netherlands is growing quickly because more people demand personalized medicines and specialized dosage forms. Growth is supported by increasing numbers of individuals having chronic conditions, patients wanting personalized treatments, and rules that encourage drug companies to introduce new innovations. To meet the needs of different patients, pharmacies are focusing on making custom formulations like creams, gels, injectables, and oral solutions. As people become more aware of health care and technology improves, the market is set up for long-term growth and more integration into mainstream health care delivery.
Current Events and Its Impacts on the Netherlands Compounding Pharmacies Market
Current Event | Description and its Impact |
Dutch Healthcare Policy Reforms and Regulatory Changes |
|
Digital Health Technology Integration and Automation |
|
Can Rising Healthcare Expenditures in the Netherlands Fuel the Growth of Compounding Pharmacies?
- Personalized Medicine Demand
- Dutch healthcare focuses on personalized treatment plans.
- For patients who are unable to take regular drugs, compounding pharmacies can make custom dosage forms, strengths, or ways to deliver them.
- Cost Efficiency
- Sometimes, compounded drugs are cheaper than brand-name drugs, especially when generics are unavailable.
- Hospitals and insurance companies in the Netherlands are very aware of costs, so compounding fills in the gaps when commercial drugs are too expensive or hard to find.
- Specialized Care Needs
- Since medicines cost so much, there is considerable amount of demand for niche therapies like pediatric formulations, hormone replacement therapy, oncology support drugs, and veterinary medicines.
- Compounding pharmacies offer these customized solutions, which reduce on waste and make it easier for patients to stick to their treatment plans.
- Regulatory Environment
- The Netherlands follows the EU GMP standards and the USP <797>/<800> guidelines for making sterile drugs.
- This strict regulation makes sure that compounded drugs meet high safety standards, which makes hospitals and doctors trust them more.
- Current Industry Events of 2026
- Market Size Estimation
- Regional Breakdown
- Competitive Landscape
- Customer Intelligence
- Segmental Analysis
- Pricing Analysis
- Key Market Drivers, Challenges & Future Trends
- Customized Insights Section
Segmental Insights
Netherlands Compounding Pharmacies Market Insights, By Product Type: Oral medications lead the market with capsules and suspensions offering versatile, patient-friendly formulations
In terms of product type, the oral medications segment is expected to lead the market with 43.7% share in 2026, due to their easy to use, patients follow the instructions, and they can be used in many different ways. Capsules, suspensions, and tablets are often used to treat long-term conditions as they allow for exact dosing and customization. They are the best choice due to their versatility in medical needs, which will keep them at the top of the market in 2026.
For instance, in February 2025, CurifyLabs' compounding technology has been adopted by the Prinses Máxima Center in Utrecht, Netherlands, to improve personalized treatments for children. This innovative concept is all about making custom oral forms like suspensions and capsules, which will make it easier for kids to take their medicine and make it safer for them. It will also make compounding pharmacies more important.
Netherlands Compounding Pharmacies Market Insights, By Application: Adult medication dominates applications, driven by chronic disease prevalence and demand for personalized therapies
In terms of application, the Adult segment is expected to hold 51.3% share of the market in 2026, due to chronic diseases, lifestyle-related disorders, and the need for personalized therapies are all on the rise. Adults make up the largest group of patients, and they need special forms of medicine like capsules, tablets, and topical solutions. This dominance shows the significance compounding is becoming for meeting the complex healthcare needs of adults.
Netherlands Compounding Pharmacies Market Insights, By Therapeutic Area: Hormone replacement therapy tops therapeutic areas, fueled by rising demand for bioidentical hormone treatments
In terms of therapeutic area, the hormone replacement therapy segment is projected to account for 56.2% share of the market in 2026. Hormone replacement therapy is the most popular type of treatment right now. This is fueled by increasing individuals are learning about bioidentical hormones and prefer personalized treatment. Compounded medications like capsules, creams, and gels provides flexibility in dosage and delivery. The fact that HRT is so popular shows the significance it is for fixing hormonal imbalances and making life better.
Netherlands Compounding Pharmacies Market Insights, By Facility: Community pharmacies dominate facilities, providing accessible, personalized compounding services to the largest patient base
In terms of facility, the community pharmacies segment is projected to capture 60% of the market in 2026. Their strengths are that they are accessible, offer personalized services, and have strong relationships with patients. They make custom formulations available directly to consumers, which makes them the main place for compounded medications, as opposed to hospital-based compounding.
Market Report Scope
Netherlands Compounding Pharmacies Market Report Coverage
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 484.70 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 7.4% | 2033 Value Projection: | USD 798.7 Mn |
| Segments covered: |
| ||
| Companies covered: | GMP Apotheek Mierlo Hout, Apotheek A15, Vemedia, and Fagron. | ||
| Growth Drivers: |
| ||
| Restraints & Challenges: |
| ||
Netherlands Compounding Pharmacies Market Driver
Personalized Medicine Demand
Patients in the Netherlands require a greater variety of customized dosages, formulations, and delivery methods that standard drugs cannot provide them. Compounding pharmacies meet these needs by making custom medicines for children, the elderly, and people with allergies or other medical needs. This trend toward personalization is a big reason why the market is growing, and it fits with the patient-centered approach of modern healthcare. In recognition of this, the Netherlands compounding pharmacies market share is growing, and pharmacies are becoming more established in specialized care and unique pharmaceutical services.
Chronic Disease Prevalence
The growing number of people in the Netherlands with diabetes, heart disease, and cancer is increasing the need for specialized treatments. Compounded medications are incredibly necessary for managing pain, hormone replacement therapy (HRT), and oncology support treatments as they can be customized in ways that cannot mass-produced drugs. This growing burden of chronic diseases means that compounding services continue to be needed, indicating the significance they have been in healthcare. As a result, the Netherlands Compounding Pharmacies Market demand keeps going up as patients and providers look for personalized ways to deal with long-term, complicated health problems.
Netherlands Compounding Pharmacies Market Opportunity
Integration of Advanced Technology
The Netherlands compounding pharmacies sector is evolving as a result of the use of automation, sterile compounding systems, and digital prescription platforms. These new ideas make things work better, reduce mistakes made by people, and make sure that strict EU pharmaceutical standards are followed. Pharmacies that use advanced technology can grow their business, make patients safer, and provide reliable, personalized medications. This modernization not only gives them a stronger competitive edge, but it also helps them grow over the long term. The Netherlands Compounding Pharmacies Market forecast shows that steady growth will be driven by the use of new technologies.
Analyst Opinion (Expert Opinion)
The Netherlands' compounding pharmacies market value is essential for personalized medication delivery as they support individuals with unmet needs by regular commercial drugs. Data from community pharmacies show that compounded preparations constitute a small but important part of all prescriptions filled. Most of these specific formulations are topical and oral products. Specialized compounding work has moved to dedicated facilities, and many community pharmacies now send their work to central compounders that provide custom medicines to a wide range of healthcare providers.
The Netherlands has strict rules that require pharmacists to be licensed and follow Good Manufacturing Practice (GMP) and national inspection standards. This set of rules helps with quality control and makes compounded medicines more trustworthy in clinical settings. There are about a few dozen specialized compounding pharmacies that work under different legal structures. They make patient-specific formulations for both community and hospital pharmacies.
Compounding services help with things like dermatological needs, adjusting doses for children, and making other drug preparations that major drug companies do not produce. Tailoring medications includes making different dosage forms and formulations for specific groups of patients, such as liquids, creams, and special oral forms.
Demographic factors like aging and the high number of people with chronic conditions affect market dynamics. These factors drive the need for personalized medication approaches. The sector's growth within the larger Dutch pharmaceutical landscape is also helped by the presence of established compounding companies and ongoing investments in technology to improve formulation accuracy.
Speak to the analyst
Want personalized insights?
Take the findings above to one of our principal consultants, or have the report rebuilt around the segments, geographies and competitors you actually track.
Recent Developments
- In September 2025, the Royal Dutch Pharmacists Association (KNMP) won the Health Promotion Campaign Award for its "Running out is not an option" campaign. The campaign focused on medicine shortages and highlighted the role of pharmacists in making sure that care continues, including compounding medicines. It was recognized around the world in Copenhagen.
Market Segmentation
- By Product Type
- Mouthwashes
- Orals Medications
- Capsule
- Lollipops
- Lozenges
- Suspensions
- Tablets
- Suppositories
- Topical Medications
- Cream
- Gels
- Lotions
- Ointments
- By Application
- Medication for Adults
- Medication for Children
- Medication for Geriatric
- Medication for Veterinary
- By Therapeutic Area
- Hormone Replacement Therapy
- Pain Management
- By Facilities
- Community Pharmacies
- Hospitals
- Netherlands Compounding Pharmacies Market: Competitive Landscape
- GMP Apotheek Mierlo Hout
- Apotheek A15
- Vemedia
- Fagron
Sources
Primary Research Interviews
- Compounding Pharmacy Owners & Managers (Netherlands)
- Hospital Pharmacists & Clinical Pharmacy Heads
- Pharmaceutical Compounding Technicians
- Healthcare Regulatory & Compliance Consultants
- Physicians Prescribing Personalized Medicines
- Others
Databases
- Bloomberg Terminal
- Thomson Reuters Eikon
- IQVIA
- Others
Magazines
- Pharmaceutical Journal
- European Pharmaceutical Review
- Pharmacy Magazine (EU)
- Hospital Pharmacy Europe
- Others
Journals
- International Journal of Pharmaceutics
- European Journal of Hospital Pharmacy
- Journal of Pharmaceutical Sciences
- American Journal of Health-System Pharmacy
- Others
Newspapers
- Financial Times
- Reuters
- Bloomberg News
- The Guardian – Healthcare & Pharma Section
- Others
Associations
- Royal Dutch Pharmacists Association (KNMP)
- European Association of Hospital Pharmacists (EAHP)
- International Pharmaceutical Federation (FIP)
- European Medicines Agency (EMA)
- Others
Public Domain Sources
- Netherlands Ministry of Health, Welfare and Sport
- Dutch Medicines Evaluation Board (CBG-MEB)
- European Medicines Agency (EMA)
- OECD Health Statistics
- World Health Organization (WHO)
- Others
Proprietary Elements
- CMI Data Analytics Tool
- Proprietary CMI Existing Repository of Information for the Last 8 Years
Get access to 250+ pages report
Every segment, forecast, competitor profile and data table behind the analysis above — available for instant download.
- ESOMAR Member
- ISO 9001:2015 Certified
- D-U-N-S Registered
- GDPR & CCPA Compliant
Missing comfort of reading report in your local language? Find your preferred language:
Transform your Strategy with Exclusive Trending Reports
Frequently Asked Questions
The Netherlands compounding pharmacies market is estimated to be valued at USD 484.70 Mn in 2026, and is expected to reach USD 798.7 Mn by 2033.
Major players operating in the Netherlands compounding pharmacies market include GMP Apotheek Mierlo Hout, Apotheek A15, Vemedia, and Fagron.
Strict regulatory compliance is expected to hinder growth of the market over the forecast period.
Personalized Medicine Demand and Chronic Disease Prevalence are expected to propel growth of the market over the forecast period.
Rising preference for HRT drugs indicated for menopausal symptoms, men’s health (andropause), and weight loss is one of the major trends that is observed in the market.
Among product type, oral medication segment held a dominant position in the Netherlands compounding pharmacies market in 2026, accounting for 43.7% share in terms of value.